Targeting PML in triple negative breast cancer elicits growth suppression and senescence.
Ontology highlight
ABSTRACT: Oncogene addiction postulates that the survival and growth of certain tumor cells is dependent upon the activity of one oncogene, despite their multiple genetic and epigenetic abnormalities. This phenomenon provides a foundation for molecular targeted therapy and a rationale for oncogene-based stratification. We have previously reported that the Promyelocytic Leukemia protein (PML) is upregulated in triple negative breast cancer (TNBC) and it regulates cancer-initiating cell function, thus suggesting that this protein can be therapeutically targeted in combination with PML-based stratification. However, the effects of PML perturbation on the bulk of tumor cells remained poorly understood. Here we demonstrate that TNBC cells are addicted to the expression of this nuclear protein. PML inhibi
SUBMITTER: Arreal L
PROVIDER: S-EPMC7104349 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA